Status:
COMPLETED
Time-Effect of Montelukast Protection
Lead Sponsor:
Universita di Verona
Conditions:
Exercise-Induced Asthma
Asthma
Eligibility:
All Genders
6-14 years
Phase:
PHASE4
Brief Summary
The aim of this study is to verify MNT time of onset of protection against EIB in asthmatic children by evaluating different time intervals between dosing and challenge, after a single-dose and after ...
Detailed Description
Within few days after a baseline exercise challenge, children was randomized to a double blind, placebo-controlled, three day doses, crossover study design. In practice each eligible patient was rando...
Eligibility Criteria
Inclusion
- children with exercise-induced asthma
Exclusion
- viral infections
- montelukast treatment
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT00935415
Start Date
January 1 2007
End Date
August 1 2008
Last Update
July 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Dept Hospital of Bolzano
Bolzano, Italy